These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21964028)

  • 1. Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans.
    Barratt-Due A; Thorgersen EB; Lindstad JK; Pharo A; Lissina O; Lambris JD; Nunn MA; Mollnes TE
    J Immunol; 2011 Nov; 187(9):4913-9. PubMed ID: 21964028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata.
    Nunn MA; Sharma A; Paesen GC; Adamson S; Lissina O; Willis AC; Nuttall PA
    J Immunol; 2005 Feb; 174(4):2084-91. PubMed ID: 15699138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined inhibition of complement C5 and CD14 markedly attenuates inflammation, thrombogenicity, and hemodynamic changes in porcine sepsis.
    Barratt-Due A; Thorgersen EB; Egge K; Pischke S; Sokolov A; Hellerud BC; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn M; Scott H; Mollnes TE
    J Immunol; 2013 Jul; 191(2):819-27. PubMed ID: 23761634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubata.
    Hepburn NJ; Williams AS; Nunn MA; Chamberlain-Banoub JC; Hamer J; Morgan BP; Harris CL
    J Biol Chem; 2007 Mar; 282(11):8292-9. PubMed ID: 17215252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soft tick Ornithodoros moubata salivary protein OmCI is a potent inhibitor to prevent avian complement activation.
    Frye AM; Hart TM; Tufts DM; Ram S; Diuk-Wasser MA; Kraiczy P; Blom AM; Lin YP
    Ticks Tick Borne Dis; 2020 Mar; 11(2):101354. PubMed ID: 31866440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of OMCI, a novel lipocalin inhibitor of the complement system.
    Roversi P; Lissina O; Johnson S; Ahmat N; Paesen GC; Ploss K; Boland W; Nunn MA; Lea SM
    J Mol Biol; 2007 Jun; 369(3):784-93. PubMed ID: 17445829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.
    Landsem A; Fure H; Krey Ludviksen J; Christiansen D; Lau C; Mathisen M; Bergseth G; Nymo S; Lappegård KT; Woodruff TM; Espevik T; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2019 Apr; 196(1):97-110. PubMed ID: 30444525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood.
    Thorgersen EB; Pharo A; Haverson K; Axelsen AK; Gaustad P; Kotwal GJ; Sfyroera G; Mollnes TE
    Infect Immun; 2009 Feb; 77(2):725-32. PubMed ID: 19047409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs.
    Thorgersen EB; Hellerud BC; Nielsen EW; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Fosse E; Tønnessen TI; Johansen HT; Castellheim A; Mollnes TE
    FASEB J; 2010 Mar; 24(3):712-22. PubMed ID: 19841036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice.
    Huber-Lang M; Barratt-Due A; Pischke SE; Sandanger Ø; Nilsson PH; Nunn MA; Denk S; Gaus W; Espevik T; Mollnes TE
    J Immunol; 2014 Jun; 192(11):5324-31. PubMed ID: 24790148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14.
    Egge KH; Thorgersen EB; Pischke SE; Lindstad JK; Pharo A; Bongoni AK; Rieben R; Nunn MA; Barratt-Due A; Mollnes TE
    Immunobiology; 2015 Aug; 220(8):999-1005. PubMed ID: 25956456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis.
    Mohr M; Höpken U; Oppermann M; Mathes C; Goldmann K; Siever S; Götze O; Burchardi H
    Eur J Clin Invest; 1998 Mar; 28(3):227-34. PubMed ID: 9568469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
    Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
    J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.
    Brekke OL; Christiansen D; Fure H; Pharo A; Fung M; Riesenfeld J; Mollnes TE
    Mol Immunol; 2008 Aug; 45(14):3804-13. PubMed ID: 18606453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
    Mollnes TE; Brekke OL; Fung M; Fure H; Christiansen D; Bergseth G; Videm V; Lappegård KT; Köhl J; Lambris JD
    Blood; 2002 Sep; 100(5):1869-77. PubMed ID: 12176911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PASylated Coversin, a C5-Specific Complement Inhibitor with Extended Pharmacokinetics, Shows Enhanced Anti-Hemolytic Activity in Vitro.
    Kuhn N; Schmidt CQ; Schlapschy M; Skerra A
    Bioconjug Chem; 2016 Oct; 27(10):2359-2371. PubMed ID: 27598771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.
    Pischke SE; Gustavsen A; Orrem HL; Egge KH; Courivaud F; Fontenelle H; Despont A; Bongoni AK; Rieben R; Tønnessen TI; Nunn MA; Scott H; Skulstad H; Barratt-Due A; Mollnes TE
    Basic Res Cardiol; 2017 May; 112(3):20. PubMed ID: 28258298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of selective complement and CD14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood.
    Brekke OL; Waage C; Christiansen D; Fure H; Qu H; Lambris JD; Østerud B; Nielsen EW; Mollnes TE
    Adv Exp Med Biol; 2013; 735():123-36. PubMed ID: 23402023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.
    Skjeflo EW; Christiansen D; Landsem A; Stenvik J; Woodruff TM; Espevik T; Nielsen EW; Mollnes TE
    Mol Immunol; 2019 Aug; 112():131-139. PubMed ID: 31102985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.